- •Foreword
- •Preface
- •Contents
- •Contributors
- •Introduction
- •Noninfectious Retinal Manifestations
- •Cytomegalovirus Retinitis
- •Necrotizing Herpetic Retinitis (by Varicella Zoster)
- •Toxoplasmic Retinochoroiditis
- •Syphilitic Uveitis, Papillitis, and Retinitis
- •Candida Vitritis and Retinitis
- •Pneumocystis carinii Choroiditis
- •Cryptococcus neoformans Chorioretinitis
- •Mycobacterium Choroiditis
- •B-Cell Lymphoma
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Etiologic Agent
- •Toxocara canis
- •Ancylostoma caninum
- •Baylisascaris procyonis
- •Trematodes
- •Mode of Transmission
- •Diagnosis and Pathogenesis
- •Early Stage
- •Late Stage
- •Ancillary Tests
- •Serologic Test
- •Fluorescein Angiography
- •Visual Field Studies
- •Scanning Laser Ophthalmoscopy (SLO)
- •Optic Coherence Tomography (OCT)
- •GDx® Nerve Fiber Analyzer
- •Differential Diagnosis
- •Management
- •Laser Treatment
- •Oral Treatment
- •Pars Plana Vitrectomy (PPV)
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Epidemiology
- •Etiology and Pathogenesis
- •Systemic Manifestations
- •Clinical Intraocular Manifestations
- •Diagnosis
- •Treatment
- •Surgical Technique
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Pathogenesis and Life Cycle
- •Clinical Manifestations
- •Epidemiology
- •Diagnosis
- •Differential Diagnosis
- •Management
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Current Epidemiology
- •Eyelid Tuberculosis
- •Conjunctival Tuberculosis
- •Scleral Tuberculosis
- •Phlyctenulosis
- •Corneal Tuberculosis
- •Uveal Tuberculosis
- •Anterior Uveitis
- •Intermediate Uveitis
- •Posterior Uveitis (Choroidal Tuberculosis)
- •Orbital Tuberculosis
- •Retinal Tuberculosis
- •Retinal Vascular Disease
- •Tuberculous Panophthalmitis
- •Neuro-ophthalmological Aspects
- •Ocular Tuberculosis Associated with Mycobacterium bovis
- •Rare Presentations
- •Isolated Macular Edema
- •Isolated Ocular Tuberculosis
- •Intraocular Infection with Pigmented Hypopyon
- •Ocular Tuberculosis After Corticosteroid Therapy
- •Systemic Investigations
- •Ocular Investigations
- •Corticosteroid Therapy
- •Antitubercular Therapy
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Pathogenesis
- •Clinical Manifestations
- •Epidemiology
- •Diagnosis
- •Differential Diagnosis
- •Management
- •Pyrimethamine
- •Sulfonamides
- •Folinic Acid
- •Clindamycin
- •Azithromycin
- •Trimethoprim and Sulfamethoxazole
- •Spiramycin
- •Atovaquone
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Bartonellosis
- •Epidemiology
- •Microbiology
- •Clinical Findings in Cat Scratch Disease
- •Systemic Manifestations
- •Ocular Manifestations
- •Parinaud’s Oculoglandular Syndrome (POGS)
- •Retinal and Choroidal Manifestations and Complications
- •Neuroretinitis (Leber’s Neuroretinitis)
- •Multifocal Retinitis and Choroiditis
- •Vasculitis and Vascular Occlusion
- •Peripapillary Bacillary Angiomatosis
- •Uveitis
- •Diagnosis
- •Biopsy and Testing
- •Therapy
- •Controversies and Perspectives
- •Clinical Pearls
- •Lyme Disease
- •Diagnosis
- •Ocular Manifestations
- •Intermediate Uveitis
- •Retinal Vasculitis, Branch Retinal Artery, Retinal Vein Occlusion, and Cotton-Wool Spots
- •Neuroretinitis
- •Other Ocular Manifestations
- •Cystoid Macular Edema and Macular Pucker
- •Retinal Pigment Epithelial Detachment
- •Retinitis Pigmentosa-Like Retinopathy
- •Choroidal Neovascular Membrane
- •Acute Posterior Multifocal Placoid Pigment Epitheliopathy-Like Picture
- •Retinal Tear
- •Ciliochoroidal Detachment
- •Therapy
- •Controversies and Perspectives
- •Clinical Pearls
- •Syphilis
- •Ocular Manifestations
- •Retina and Choroid
- •Retinal Vasculature
- •Optic Disk
- •Association Between HIV and Syphilis
- •Clinical Importance of Ocular Syphilis
- •Therapy
- •Controversies and Perspectives
- •Clinical Pearls
- •References
- •Introduction
- •Acute Retinal Necrosis
- •Causative Virus
- •Epidemiology
- •Virological Diagnosis
- •Clinical Course
- •Treatment
- •Cytomegalovirus
- •Diagnosis
- •Staging and Progression
- •Laboratory Findings
- •Treatment
- •Pharmacologic
- •Surgical
- •Patient Follow-up
- •Epidemiology
- •Diagnosis
- •HIV Disease
- •HIV Therapy
- •Ocular Manifestations of HIV
- •Progressive Outer Retinal Necrosis
- •Diagnosis
- •Etiology
- •Therapy
- •Rubella
- •West Nile Virus
- •Other Systemic Illnesses
- •Controversies and Perspectives
- •What Is the Best Surgical Approach for Repair of Secondary Retinal Detachment?
- •Focal Points
- •References
- •Introduction
- •Causative Organisms
- •Candidiasis
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Aspergillus Retinitis
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Cryptococcal Chorioretinitis
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Coccidioides immitis Chorioretinitis
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Histoplasma Chorioretinitis
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Sporothrix schenckii Chorioretinitis
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Controversies and Perspectives
- •Focal Points
- •References
- •10: Endogenous Endophthalmitis
- •Introduction
- •Clinical Findings
- •Diagnosis
- •How to Culture
- •Polymerase Chain Reaction
- •Treatment
- •Systemic Antibiotics
- •Intravitreous Antibiotics
- •Corticosteroid Therapy
- •Vitrectomy
- •Prognosis
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Etiology
- •Genetic Features
- •Immunopathogenesis
- •Diagnosis
- •Posterior Segment Findings
- •Management
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Epidemiology
- •Prevalence and Incidence
- •Age of Onset
- •The Gender Factor
- •Etiopathogenesis
- •Clinical Features and Diagnosis
- •Ocular Involvement
- •Posterior Segment Involvement
- •Fluorescein Angiography
- •Indocyanine Green Angiography
- •Optical Coherence Tomography
- •Other Ocular Manifestations
- •Complications
- •Histopathology
- •Prognosis of Ocular Disease
- •Juvenile Behçet’s Disease
- •Pregnancy and Behçet’s Disease
- •Differential Diagnosis
- •Management of Ocular Disease
- •Medical Treatment
- •Colchicine
- •Corticosteroids
- •Intravitreal Triamcinolone
- •Cyclosporin A and Tacrolimus (FK506)
- •Anti-tumor Necrosis Factor Treatment
- •Cytotoxic and Other Immunosuppressive Agents
- •Tolerization Therapy
- •Laser Treatment
- •Plasmapheresis
- •Cataract Surgery
- •Trabeculectomy
- •Vitrectomy
- •Controversies and Perspectives
- •Pearls
- •References
- •13: Intraocular Lymphoma
- •Introduction
- •Historical Background
- •Epidemiology
- •Etiology
- •Imaging
- •Diagnosis and Pathology
- •Treatment
- •Controversies and Perspectives
- •Focal Points
- •Acknowledgments
- •References
- •14: Choroidal and Retinal Metastasis
- •Introduction
- •Primary Cancer Sites Leading to Intraocular Metastasis
- •Intraocular Metastasis Onset
- •Choroidal Metastases
- •Ciliary Body Metastases
- •Iris Metastases
- •Retinal Metastases
- •Optic Disk Metastases
- •Vitreous Metastases
- •Ocular Paraneoplastic Syndromes
- •Diagnostic Evaluation for Ocular Metastasis
- •Systemic Evaluation
- •Fluorescein Angiography
- •Indocyanine Green Angiography
- •Ultrasonography
- •Optical Coherence Tomography
- •Computed Tomography
- •Magnetic Resonance Imaging
- •Fine-Needle Aspiration Biopsy
- •Surgical Biopsy
- •Pathology of Ocular Metastasis
- •Observation
- •Radiotherapy
- •Surgical Excision, Enucleation
- •Patient Prognosis
- •Controversies and Perspective
- •Pearls
- •References
- •Introduction
- •CAR Cases
- •CAR Case 1: CAR Secondary to Esthesioneuroblastoma (Olfactory Neuroblastoma)
- •CAR Case 2: CAR Associated with Metastatic Breast Cancer
- •CAR Case 3: Paraneoplastic Optic Neuritis and Retinitis Associated with Small Cell Lung Cancer
- •Paraneoplastic Retinopathy: Melanoma-Associated Retinopathy (MAR)
- •MAR Case
- •Pearls
- •References
- •Introduction
- •Epidemiology
- •Pathophysiology
- •Clinical Presentation
- •Ulcerative Colitis
- •Crohn’s Disease
- •Ocular Manifestations
- •Posterior Segment Lesions
- •Treatment of Ocular Manifestations
- •Whipple’s Disease
- •Diagnosis
- •Extraintestinal Manifestations
- •Central Nervous System
- •Others
- •Treatment
- •Avitaminosis A
- •Pancreatitis
- •Familial Adenomatous Polyposis
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Demographics
- •Genetics
- •Fundus Manifestations
- •Management
- •Demographics
- •Genetics
- •Ophthalmologic Features
- •Fundus Manifestations
- •Management
- •Demographics
- •Genetics
- •Fundus Manifestations
- •Management
- •Genetics
- •Ophthalmologic Features
- •Fundus Manifestations
- •Management
- •Genetics
- •Fundus Manifestations
- •Management
- •Genetics
- •Fundus Manifestations
- •Controversies and Perspectives
- •References
- •Pathogenesis and Laboratory Findings
- •Innate Immune System Activation
- •Increased Availability of Self-antigen and Apoptosis
- •Adaptive Immune Response
- •Damage to Target Organs
- •General Clinical Findings
- •Ocular Symptoms
- •Posterior Ocular Manifestations
- •Mild Retinopathy
- •Vaso-occlusive Retinopathy
- •Lupus Choroidopathy
- •Anterior Visual Pathway
- •Posterior Visual Pathway
- •Oculomotor System
- •Anterior Ocular Manifestations
- •Drug-Related Ocular Manifestations
- •General Management
- •Controversies and Perspectives
- •Focal Points
- •References
- •19: Vogt–Koyanagi–Harada Disease
- •Introduction
- •History
- •Epidemiology
- •Immunopathogenesis
- •Histopathology
- •Immunogenetics
- •Clinical Features
- •Extraocular Manifestations
- •Ancillary Test
- •Fluorescein Angiography (FA)
- •Indocyanine Green Angiography (ICGA)
- •Cerebrospinal Fluid Analysis (CSF)
- •Ultrasonography (USG)
- •Ultrasound Biomicroscopy (UBM)
- •Magnetic Resonance Image (MRI)
- •Electrophysiology
- •Differential Diagnosis
- •Sympathetic Ophthalmia
- •Primary Intraocular B-Cell Lymphoma
- •Posterior Scleritis
- •Uveal Effusion Syndrome
- •Sarcoidosis
- •Lyme Disease
- •Treatment
- •Complications
- •Prognosis
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •General
- •Genetics
- •Pathogenesis
- •Ocular Pathology
- •Lens
- •Retina
- •Lens Subluxation
- •Clinical Findings
- •Pathogenesis
- •Differential Diagnosis
- •Treatment
- •Retinal Detachment
- •Clinical Findings
- •Pathogenesis
- •Therapy
- •Controversies and Perspectives
- •Focal Points
- •References
- •21: Diabetic Retinopathy
- •Introduction
- •Pathogenesis
- •Risk Factors
- •Duration of Disease
- •Glucose Control
- •Blood Pressure Control
- •Lipid Control
- •Other Factors
- •Proliferative Diabetic Retinopathy
- •Advanced Eye Disease
- •Diabetic Macular Edema
- •Management
- •Glycemic Control
- •Blood Pressure Control
- •Serum Lipid Control
- •Aspirin Treatment
- •Laser Photocoagulation
- •Vitrectomy
- •Pharmacotherapy
- •Corticosteroids
- •Triamcinolone Acetonide
- •Fluocinolone Acetonide
- •Extended-Release Dexamethasone
- •Pegaptanib
- •Ranibizumab
- •Bevacizumab
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Hypertensive Retinopathy
- •Hypertensive Choroidopathy
- •Indirect Effects
- •Controversies and Perspectives
- •Summary
- •Focal Points
- •References
- •Introduction
- •Anemia
- •Aplastic Anemia
- •Hemoglobinopathies
- •Sickle Cell Disease
- •Thalassemia
- •Deferoxamine Toxicity
- •Autoimmune Hemolytic Anemia
- •Antiphospholipid Antibody Syndrome
- •Hemophilia and Platelet Disorders
- •Myelodysplastic Disorders
- •Myeloproliferative Disorders
- •Chronic Myelogenous Leukemia
- •Polycythemia Vera
- •Essential Thrombocythemia
- •Leukemias
- •Acute Myeloid Leukemia
- •Lymphoid
- •Lymphomas
- •B Cell Lymphoma
- •Hodgkin’s Lymphoma
- •Plasma Cell Disorders
- •Plasmacytoma/Multiple Myeloma
- •Plasma Cell Leukemia
- •T Cell Lymphomas
- •Controversies/Perspectives
- •Roth Spots
- •Anti-VEGF Therapy
- •Focal Points
- •Anemia
- •Hemoglobinopathies
- •Myelodysplastic Syndrome
- •Myeloproliferative Neoplasms
- •Leukemia
- •Lymphoma
- •References
- •24: The Ocular Ischemic Syndrome
- •Introduction
- •Demography
- •Etiology
- •Symptoms
- •Loss of Vision
- •Amaurosis Fugax
- •Pain
- •Visual Acuity
- •Signs
- •External
- •Anterior Segment Changes
- •Posterior Segment Findings
- •Diagnostic Studies
- •Fluorescein Angiography
- •Electroretinography
- •Carotid Artery Imaging
- •Others
- •Systemic Associations
- •Differential Diagnosis
- •Treatment
- •Systemic Therapy: Carotid Artery
- •Ophthalmic Therapy
- •Controversies and Perspectives
- •Focal Points
- •References
- •25: Ocular Manifestations of Pregnancy
- •Introduction
- •Physiologic Changes
- •Intraocular Pressure
- •Cornea
- •Pathologic Conditions
- •Pregnancy-Induced Hypertension
- •Clinical Features
- •Ocular Manifestations
- •HELLP Syndrome
- •Management of PIH
- •Prognosis
- •Central Serous Retinopathy
- •Occlusive Vascular Disorders
- •Purtscher’s-Like Retinopathy
- •Disseminated Intravascular Coagulation (DIC)
- •Thrombotic Thrombocytopenic Purpura (TTP)
- •Amniotic Fluid Embolism
- •Preexisting Conditions
- •Diabetic Retinopathy
- •Progression
- •Factors Associated with Progression
- •Pathophysiology of Progression
- •Treatment Criteria for Diabetic Retinopathy
- •Follow-up Guidelines
- •Intraocular Tumors
- •Uveal Melanoma
- •Choroidal Osteoma
- •Choroidal Hemangioma
- •Ocular Medications
- •Topical Drops
- •Diagnostic Agents
- •Summary
- •Focal Points
- •References
- •Introduction
- •Toxicity with Diffuse Retinal Changes
- •Toxicity with Pigmentary Degeneration
- •Quinolines
- •Phenothiazines
- •Deferoxamine
- •Toxicity with Crystalline Deposits
- •Tamoxifen
- •Canthaxanthine
- •Toxicity Without Fundus Changes
- •Cardiac Glycosides
- •Phosphodiesterase Inhibitors
- •Toxicity with Retinal Edema
- •Methanol
- •Toxicity with Retinal Vascular Changes
- •Talc
- •Oral Contraceptives
- •Interferon
- •Toxicity with Maculopathy
- •Niacin
- •Sympathomimetics
- •Toxicity with Retinal Folds
- •Sulfanilamide-Like Medications
- •Summary
- •Focal Points
- •References
- •Introduction
- •Diabetes
- •Vascular Disease
- •Hypertensive Retinopathy
- •Hypertensive Optic Neuropathy
- •Thrombotic Microangiopathy
- •Dysregulation of the Alternative Complement Pathway with Renal and Ocular Fundus Changes
- •Papillorenal Syndrome
- •Ciliopathies
- •Senior-Loken Syndrome and Related Syndromes with Nephronophthisis
- •Other Rare Metabolic Diseases
- •Congenital Disorders of Glycosylation (CDG)
- •Cystinosis
- •Fabry Disease
- •Peroxisomal Diseases: Refsum Disease
- •Neoplastic Diseases with Kidney and Ocular Involvement
- •von Hippel-Lindau Disease
- •Light Chain Deposition Disease
- •Controversies and Perspectives
- •Focal Points
- •References
- •Index
52 |
J.F. Arévalo and J.V. Espinoza |
|
|
Fig. 4.6 Posterior pole granuloma superior to the optic disk with secondary fibrocellular membranes extending into the optic nerve, vitreous, and surrounding retina in a
10-year-old boy with Toxocara canis. (a) Color photograph. (b) Fluorescein angiogram
also may lead to retinal breaks in atrophic retina, creating a combined tractional-rhegmatogenous detachment [19]. An optic papillitis also can occur, usually because of an invasion of the nerve by the nematode or as an inflammatory response to the organism in another site of the eye [1].
Epidemiology
Uveitis is a common cause of vision loss, accounting for 5–20% of all cases of blindness worldwide [17]. Toxoplasmosis is the most common etiology of infectious posterior uveitis and having OT as one of the less frequent cause [20]. However, the study of the epidemiology of human toxocariasis remains problematic for a number of reasons. First, much of the epidemiology of human toxocariasis is based on serodiagnosis, which has inherent problems, and our understanding of the relationship between exposure and disease remains poor. Second, the lack of standardization of both clinical signs and symptoms and serological testing can introduce variation between studies and make comparisons difficult. Third, randomly selected data at the population level is scarce, and therefore, it is difficult to assess the public health significance of disease in different countries [4].
The prevalence of infection of dogs with adult Toxocara worms was reported to be about 25% in Western countries [3, 21], while the
rate in cats in France was 30–60% [3]. The prevalence of infection tends to decrease with increasing age of the animal and is lower in well-cared-for pet dogs than in stray or pound dogs. This high prevalence, together with the high fecundity of Toxocara and the increasing number of pet animals in Western countries, explains the high level of soil contamination with Toxocara eggs in parks, playgrounds, and other public places [3].
Recent studies have demonstrated that soil samples taken from gardens of homes where a clinical case of toxocariasis is found are likely to be contaminated. Toxocara eggs have been recovered from salads and other raw vegetables taken from such gardens [3]. Geophagia or soil eating is a specific type of pica that increases the risk of toxocariasis, especially in children living in homes with puppies that have not been dewormed. Poor personal hygiene as well as consumption of raw vegetables grown in contaminated kitchen gardens may result in chronic low-dose infections [3].
Toxocara seroprevalences range from 4% to 46% in adults and can be as high as 77.6% in school children [22], and the disease affects females and males with approximately equal frequency [17]. In the United States, the overall prevalence was found to vary between 4.6% and 7.3%, but ranged as high as 10% in the American South and over 30% for socioeconomically disadvantaged African American children. Higher
4 Posterior Pole Manifestations of Toxocariasis |
53 |
|
|
seroprevalence was also linked to markers of low socioeconomic status, including poverty and crowding and lower educational level for head of household [23, 24]. In 2008, the Centers for Disease Control and Prevention (CDC) in the United States reported on Toxocara seroprevalence from the Third National Health and Nutrition Examination Survey (NHANES III), a cross-sectional survey conducted between 1988 and 1994. The survey sampled at higher rates specific minority groups (e.g., non-Hispanic Blacks and Mexican Americans) and age groups (young children and the elderly). Based on a representative sample of just over 20,000 in individuals over the age of 6, the overall seroprevalence was 13.9% [23, 25], suggesting that ten million Americans are infected with Toxocara. However, the seroprevalence was found to be considerably higher among non-Hispanic Blacks and people living in poverty.
Based on the number of African Americans living in poverty in the United States, it has been calculated that as many as 2.8 million have toxocariasis, making this disease one of the most common infections among any underrepresented minority groups [23]. In a separate study conducted in the 1990s, high rates of toxocariasis were also found among inner-city Hispanic populations in Bridgeport and New Haven, Connecticut, especially among Puerto Rican immigrants [23, 26]. On the other hand, unlike previous reports in other countries, most patients reported with ocular toxocariasis in Japan are adult, and this prevalence may be due to the changing dietary habit in that country [14].
Diagnosis
The diagnosis of OT is difficult and, in the majority of cases, remains only presumptive. Standard diagnostic methods for ocular Toxocara are fundoscopy, imaging, and serologic testing [13].
Most patients with visceral larva migrans will manifest a leukocytosis and hypereosinophilia. On the other hand, eosinophilia is usually absent in OT. Tissue biopsy can show the presence of larvae, but because the larvae rarely are able to
finish their life cycle in human beings, stool analysis will not detect Toxocara [1]. In the absence of parasitological evidence of infection, diagnosis of toxocariasis has relied mainly on immunological methods [10, 27]. Thus, the Toxocara excreted-secreted antigens (TES) have been applied to different immunological assays. The TES-based enzyme-linked immunosorbent assay (ELISA) for detection of IgG-specific antibodies, in particular, is widely preferred for diagnostic purposes and also for seroepidemiologic surveys [10].
Toxocara is a parasite with the ability to evade the immune system, which could explain the chronicity and persistence of the infection [10]. The ELISA has made immunodiagnosis the main serologic method for detecting visceral larva migrans and for confirming the clinical suspicion of OT [1]. Moreover, measurement of avidity (functional affinity) of specific IgG antibodies seems to be useful to discriminate between chronic and early phases of the infection, as in the case for other infectious diseases. In other words, high avidity IgG antibodies are associated with the chronic phase low avidity (functional affinity) of specific IgG antibodies that are associated with the chronic phase and low avidity IgG with freshly acquired toxocariasis. There are few follow-up studies of toxocariasis patients after chemotherapy, but it has been reported that specific IgG antibody levels remain elevated for many years [10]. In toxocariasis, specific IgM antibodies were reported to occur in both acute and chronic phases, differing from most unrelated infections in which they are transient [10]. Lately, IgA and IgE have been found to be useful for diagnosis and follow-up of toxocariasis.
For VLM and some forms of covert toxocariasis, the sensitivity and specificity of the Toxocara ELISA are estimated at 78% and 92%, respectively, at a titer of 1:32 [23]. The sensitivity of the ELISA for OLM, however, is considerably less. The larvae may remain alive within the host for months, and host antibody levels may remain strongly positive for 2 or 3 years or more [23, 25]. Therefore, in the CDC, the presence of antibody titers greater than 1:32 may be considered reflective of active infection [23].
54 |
J.F. Arévalo and J.V. Espinoza |
|
|
The presence of any level of antibodies in the serum is therefore likely to support the diagnosis of Toxocara uveitis if the clinical picture raises this possibility. However, most ophthalmologists consider a serum titer of ³1:8 to be positive for OT if the patient has clinical features consistent with the diagnosis [7, 28]. On the other hand, the absence of serum antibodies does not rule out the diagnosis [17].
The possibility that T. cati might play a part in causing ocular lesions has been raised by Petithory et al., who reported positive ELISA test for T. cati in the vitreous of six out of nine patients with OLM, all nine of whom also had positive vitreous T. canis ELISA tests [29]. Therefore, testing intraocular fluid for antibodies has also been shown to be helpful in diagnosing toxocariasis. These samples often contain higher levels of antibody than the serum [17, 30]. Taking into account that establishing the diagnosis of OT based on clinical features and serologic results is unreliable, we suggest the addition of T. canis and T. cati Goldmann-Witmer coefficient (GWC) determination to the diagnostic repertoire in patients with unexplained focal chorioretinitis or vitritis [22]. Cytology of the aqueous or vitreous may play a role in the differentiation between retinoblastoma and Toxocara posterior pole granuloma in children. The presence of eosinophils in aqueous or vitreous biopsy specimens also suggests the diagnosis to toxocariasis [31].
Imaging studies, particularly ultrasound examination and computed tomography (CT), are useful. Three ecographic patterns in 11 patients with OT were reported [31, 32]: (1) a solid, highly reflective peripheral mass (located in the temporal periphery in 91%) of patients, (2) a vitreous membrane extending between the posterior pole and the mass, and (3) traction retinal detachment or fold from the posterior pole of the mass (Fig. 4.7). Also described was pseudocystic transformation of the peripheral vitreous on ultrasound biomicroscopy. Intraocular calcification is not uniformly present, but may be seen in eyes with ocular toxocariasis with significant ocular disruption or phthisis [31].
Recently, it was demonstrated that optical coherence tomography (OCT) is useful for the
differential diagnosis between Toxocara granuloma that have subretinal extension and idiopathic choroidal neovascularization in the active stage. In general, OCT examination demonstrates a Toxocara granuloma as a highly reflective mass, protruding above the retinal pigment epithelium, and sometimes surrounded by subretinal fluid (see Fig. 4.4b) [13, 33, 34].
Differential Diagnosis
Patients with OT will often seek treatment because of leukocoria. The differential diagnosis of OT varies with the clinical presentation of the disease. It includes retinoblastoma (RB), retinopathy of prematurity (ROP), congenital cataracts, persistent fetal vasculature, infectious endophthalmitis, various forms of trauma, and the general groups of severe exudative and hemorrhagic retinopathies, which may present a similar clinical picture [1].
As RB is the most common malignant intraocular neoplasm of childhood, it is critically important to distinguish it, particularly the sporadic, unilateral variant, from OT. Factors that may be helpful in making this distinction include the following: (1) mean age at presentation for OT, 7.5– 8.9 years, versus for RB, 22–23 months; (2) paucity of inflammatory stigmata in RB; and (3) continuous growth of RB lesions. Furthermore, normal levels of aqueous humor lactate dehydrogenase and phosphoglucose isomerase, the demonstration of eosinophils in vitreous or aqueous aspirates, and absence of malignant cells favor a diagnosis of OT [31].
Infectious endophthalmitis is distinguished by the history of recent trauma or ocular surgery. Acute signs of external inflammation typical for bacterial endophthalmitis are uncharacteristic in toxocariasis. However, a delayed onset with less virulent bacterial or fungal organisms needs to be differentiated. Vitreous or aqueous sampling for microscopic examination and microbiologic studies should provide a definitive diagnosis in these cases. Endogenous endophthalmitis usually occurs in the setting of immunodeficiency and positive blood cultures [8].
4 Posterior Pole Manifestations of Toxocariasis |
55 |
|
|
Fig. 4.7 Two different cases demonstrating the ultrasound characteristics of advanced ocular toxocariasis. (a) A solid, highly reflective peripheral mass and a vitreous membrane extending between the posterior pole and
the mass. (b) A tractional retinal detachment at the posterior pole from the mass (Courtesy of Guillermo Talevi, M.D., and Carina Tallano, M.D.)
Differentiation between active toxoplasmic retinochoroiditis and toxocariasis may be difficult, particularly when severe vitritis is present. Serologic studies for toxoplasmosis should provide the diagnosis information [8].
Other pediatric conditions such as ROP, familial exudative vitreoretinopathy (FEVR), persis-
tent fetal vasculature, and Coats’ disease usually present neonatally or in early infancy and lack the signs of inflammation of the posterior segment. Retinopathy of prematurity is bilateral, encountered in infants with a history of prematurity and low birth weight, and characterized by proliferative changes and membrane formation.
